Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter February 19, 2018

The effect of lncRNA HOTAIR on chemoresistance of ovarian cancer through regulation of HOXA7

  • Siwei Liu , Huajiang Lei , Fangyuan Luo , Yilin Li and Lan Xie ORCID logo EMAIL logo
From the journal Biological Chemistry

Abstract

This study aimed at investigating the biological functions of long non-coding RNAs (lncRNAs) hox transcript antisense intergenic RNA (HOTAIR) in resistant ovarian cancer cells, exploring the regulation effect of HOTAIR on HOXA7, and investigating their influence on the chemosensitivity of ovarian cancer cells. Quantitative real-time polymerase chain reaction (qRT-PCR) was applied for the verification of HOTAIR expression in resistant and sensitive groups. How HOTAIR downregulation affected cell proliferation, migration and invasion, and apoptosis were determined using the MTT assay and the colony formation assay, the Transwell assay and flow cytometry analysis, respectively. Immunohistochemistry was used to inspect the protein expression of HOXA7 in resistant and sensitive ovarian cancer tissues. The regulation relationship between HOTAIR and HOXA7 was investigated by qRT-PCR and Western blot. The effect of HOTAIR and HOXA7 on tumor growth was confirmed by the tumor xenograft model of nude mice. By knocking down HOXA7, HOTAIR downregulation restrained the ovarian cancer deterioration in functional experiments. Silencing of HOTAIR and HOXA7 could effectively inhibit tumor growth and increase chemosensitivity of ovarian tumors in nude mice. Downregulation of HOTAIR negatively affected the survival and activity of resistant ovarian cancer cells, and suppressed the expression of HOXA7. Silencing of HOTAIR and HOXA7 could increase the chemosensitivity of ovarian cancer cells, thus suppressing tumor development.

Acknowledgments

This study was supported by the 2014 Ph.D. Program Foundation of Sichuan Provincial People’s Hospital (No. 30305030832).

References

Bhatlekar, S., Fields, J.Z., and Boman, B.M. (2014). HOX genes and their role in the development of human cancers. J. Mol. Med. (Berl.) 92, 811–823.10.1007/s00109-014-1181-ySearch in Google Scholar

Coleman, R.L., Brady, M.F., Herzog, T.J., Sabbatini, P., Armstrong, D.K., Walker, J.L., Kim, B.G., Fujiwara, K., Tewari, K.S., O’Malley, D.M., et al. (2017). Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 18, 779–791.10.1016/S1470-2045(17)30279-6Search in Google Scholar

Cui, L., Xie, X.Y., Wang, H., Chen, X.L., Liu, S.L., and Hu, L.N. (2013). [Expression of long non-coding RNA HOTAIR mRNA in ovarian cancer]. Sichuan Da Xue Xue Bao Yi Xue Ban 44, 57–59. [in Chinese]Search in Google Scholar

Dong, L. and Hui, L. (2016). HOTAIR promotes proliferation, migration, and invasion of ovarian cancer SKOV3 cells through regulating PIK3R3. Med. Sci. Monit. 22, 325–331.10.12659/MSM.894913Search in Google Scholar PubMed PubMed Central

Guo, Q., Jiang, Q., Liu, W., and Bai, Y. (2016). All-trans retinoic acid inhibits HOXA7 expression in leukemia cell NB4. Cell. Mol. Biol. (Noisy-le-Grand) 62, 63–66.Search in Google Scholar

Gustafsson-Lutz, A., Back, T., Aneheim, E., Hultborn, R., Palm, S., Jacobsson, L., Morgenstern, A., Bruchertseifer, F., Albertsson, P., and Lindegren, S. (2017). Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model. EJNMMI Res. 7, 38.10.1186/s13550-017-0283-2Search in Google Scholar PubMed PubMed Central

Hu, X., Feng, Y., Zhang, D., Zhao, S.D., Hu, Z., Greshock, J., Zhang, Y., Yang, L., Zhong, X., Wang, L.P., et al. (2014). A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell 26, 344–357.10.1016/j.ccr.2014.07.009Search in Google Scholar PubMed PubMed Central

Huang, S.C., Lin, J.K., Lin, T.C., Chen, W.S., Yang, S.H., Wang, H.S., Lan, Y.T., Lin, C.C., Jiang, J.K., and Chang, S.C. (2015). Concordance of carcinoembryonic antigen ratio and response evaluation criteria in solid tumors as prognostic surrogate indicators of metastatic colorectal cancer patients treated with chemotherapy. Ann. Surg. Oncol. 22, 2262–2268.10.1245/s10434-014-4228-ySearch in Google Scholar PubMed

Ke, D., Li, H., Zhang, Y., An, Y., Fu, H., Fang, X., and Zheng, X. (2017). The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer. Oncotarget 8, 21516–21525.10.18632/oncotarget.15628Search in Google Scholar PubMed PubMed Central

Kelly, Z., Moller-Levet, C., McGrath, S., Butler-Manuel, S., Kavitha Madhuri, T., Kierzek, A.M., Pandha, H., Morgan, R., and Michael, A. (2016). The prognostic significance of specific HOX gene expression patterns in ovarian cancer. Int. J. Cancer 139, 1608–1617.10.1002/ijc.30204Search in Google Scholar PubMed

Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S., and Safe, S. (2013). HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32, 1616–1625.10.1038/onc.2012.193Search in Google Scholar PubMed PubMed Central

Kim, J.W., Kim, J.Y., Kim, J.E., Kim, S.K., Chung, H.T., and Park, C.K. (2014). HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines. Genes Cancer 5, 165–174.10.18632/genesandcancer.16Search in Google Scholar PubMed PubMed Central

Kim, H.J., Lee, D.W., Yim, G.W., Nam, E.J., Kim, S., Kim, S.W., and Kim, Y.T. (2015). Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int. J. Oncol. 46, 521–530.10.3892/ijo.2014.2758Search in Google Scholar PubMed PubMed Central

Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., et al. (2011). Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71, 6320–6326.10.1158/0008-5472.CAN-11-1021Search in Google Scholar PubMed

Li, Y., Yang, X.H., Fang, S.J., Qin, C.F., Sun, R.L., Liu, Z.Y., Jiang, B.Y., Wu, X., and Li, G. (2015). HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2. Oncol. Rep. 33, 990–996.10.3892/or.2014.3668Search in Google Scholar PubMed

Li, J., Yang, S., Su, N., Wang, Y., Yu, J., Qiu, H., and He, X. (2016). Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer. Tumour Biol. 37, 2057–2065.10.1007/s13277-015-3998-6Search in Google Scholar PubMed

Naora, H., Montz, F.J., Chai, C.Y., and Roden, R.B. (2001). Aberrant expression of homeobox gene HOXA7 is associated with mullerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response. Proc. Natl. Acad. Sci. USA 98, 15209–15214.10.1073/pnas.011503998Search in Google Scholar PubMed PubMed Central

Ota, T., Choi, K.B., Gilks, C.B., Leung, P.C., and Auersperg, N. (2006). Cell type- and stage-specific changes in HOXA7 protein expression in human ovarian folliculogenesis: possible role of GDF-9. Differentiation 74, 1–10.10.1111/j.1432-0436.2006.00053.xSearch in Google Scholar PubMed

Ota, T., Gilks, C.B., Longacre, T., Leung, P.C., and Auersperg, N. (2007). HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features. Reprod. Sci. 14, 605–614.10.1177/1933719107307781Search in Google Scholar PubMed

Ozes, A.R., Miller, D.F., Ozes, O.N., Fang, F., Liu, Y., Matei, D., Huang, T., and Nephew, K.P. (2016). NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene 35, 5350–5361.10.1038/onc.2016.75Search in Google Scholar PubMed PubMed Central

Qiu, J.J., Lin, Y.Y., Ye, L.C., Ding, J.X., Feng, W.W., Jin, H.Y., Zhang, Y., Li, Q., and Hua, K.Q. (2014). Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol. Oncol. 134, 121–128.10.1016/j.ygyno.2014.03.556Search in Google Scholar PubMed

Qiu, J.J., Wang, Y., Ding, J.X., Jin, H.Y., Yang, G., and Hua, K.Q. (2015). The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis. Exp. Cell Res. 333, 238–248.10.1016/j.yexcr.2015.03.005Search in Google Scholar PubMed

Shah, N., Jin, K., Cruz, L.A., Park, S., Sadik, H., Cho, S., Goswami, C.P., Nakshatri, H., Gupta, R., Chang, H.Y., et al. (2013). HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression. Cancer Res. 73, 5449–5458.10.1158/0008-5472.CAN-13-1178Search in Google Scholar

Siegel, R.L., Miller, K.D., and Jemal, A. (2017). Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7–30.10.3322/caac.21387Search in Google Scholar

Swisher, E.M., Lin, K.K., Oza, A.M., Scott, C.L., Giordano, H., Sun, J., Konecny, G.E., Coleman, R.L., Tinker, A.V., O’Malley, D.M., et al. (2017). Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Lancet Oncol. 18, 75–87.10.1016/S1470-2045(16)30559-9Search in Google Scholar

Tang, B., Qi, G., Sun, X., Tang, F., Yuan, S., Wang, Z., Liang, X., Li, B., Yu, S., Liu, J., et al. (2016). HOXA7 plays a critical role in metastasis of liver cancer associated with activation of Snail. Mol. Cancer 15, 57.10.1186/s12943-016-0540-4Search in Google Scholar PubMed PubMed Central

Teschendorff, A.E., Lee, S.H., Jones, A., Fiegl, H., Kalwa, M., Wagner, W., Chindera, K., Evans, I., Dubeau, L., Orjalo, A., et al. (2015). HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Med. 7, 108.10.1186/s13073-015-0233-4Search in Google Scholar PubMed PubMed Central

Troiano, G., Caponio, V.C.A., Boldrup, L., Gu, X., Muzio, L.L., Sgaramella, N., Wang, L., and Nylander, K. (2017). Expression of the long non-coding RNA HOTAIR as a prognostic factor in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Oncotarget 8, 73029–73036.10.18632/oncotarget.20373Search in Google Scholar PubMed PubMed Central

Wang, Y., Wang, H., Song, T., Zou, Y., Jiang, J., Fang, L., and Li, P. (2015). HOTAIR is a potential target for the treatment of cisplatinresistant ovarian cancer. Mol. Med. Rep. 12, 2211–2216.10.3892/mmr.2015.3562Search in Google Scholar PubMed

Xiao, F., Bai, Y., Chen, Z., Li, Y., Luo, L., Huang, J., Yang, J., Liao, H., and Guo, L. (2014). Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur. J. Cancer 50, 1541–1554.10.1016/j.ejca.2014.01.024Search in Google Scholar PubMed

Yang, G., Lu, X., and Yuan, L. (2014). LncRNA: a link between RNA and cancer. Biochim. Biophys. Acta 1839, 1097–1109.10.1016/j.bbagrm.2014.08.012Search in Google Scholar PubMed

Yiwei, T., Hua, H., Hui, G., Mao, M., and Xiang, L. (2015). HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion. Med. Sci. Monit. 21, 1856–1863.10.12659/MSM.893528Search in Google Scholar PubMed PubMed Central

Yu, X. and Li, Z. (2015). Long non-coding RNA HOTAIR: a novel oncogene. Mol. Med. Rep. 12, 5611–5618.10.3892/mmr.2015.4161Search in Google Scholar PubMed

Yu, Y., Lv, F., Liang, D., Yang, Q., Zhang, B., Lin, H., Wang, X., Qian, G., Xu, J., and You, W. (2017). HOTAIR may regulate proliferation, apoptosis, migration and invasion of MCF-7 cells through regulating the P53/Akt/JNK signaling pathway. Biomed. Pharmacother. 90, 555–561.10.1016/j.biopha.2017.03.054Search in Google Scholar PubMed

Zhang, Y., Cheng, J.C., Huang, H.F., and Leung, P.C. (2013). Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha. Biochem. Biophys. Res. Commun. 440, 652–657.10.1016/j.bbrc.2013.09.121Search in Google Scholar PubMed

Received: 2017-10-23
Accepted: 2017-12-08
Published Online: 2018-02-19
Published in Print: 2018-04-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 24.5.2024 from https://www.degruyter.com/document/doi/10.1515/hsz-2017-0274/html
Scroll to top button